Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Capecitabine pharmacology

Lostao, M.P., Fernandez-Veledo, S., Guillen-Gomez, E., Larrayoz, l.M., Lloberas, J., Casado, F.J., and Pastor-Anglada, M. (2001) Role of the human concentrative nucleoside transporter (hCNTl) in the cytotoxic action of 5 -deoxy-5-fluorouridine, an active intermediate metabolite of capecitabine, a novel oral anticancer drug. Molecular Pharmacology, 59 (6), 1542-1548. [Pg.79]

Wagstaff AJ, Ibbotson T, Goa KL. Capecitabine areview of its pharmacology and therapeutic efficacy in the management of advanced breast cancer. Drags 2003 63 217-236. [Pg.2326]

Gieschke, R., Burger, H.-U., Reigner, B., Blesch, K.S., and Steimer, J.-L. Population pharmacokinetics and concentration-effect relationships of capecitabine metabolites in colorectal cancer patients. British Journal of Clinical Pharmacology 2003 55 252-263. [Pg.340]

See other pages where Capecitabine pharmacology is mentioned: [Pg.1350]    [Pg.286]    [Pg.579]    [Pg.1310]    [Pg.60]   
See also in sourсe #XX -- [ Pg.60 , Pg.61 ]



SEARCH



Capecitabin

© 2024 chempedia.info